233552 Cobra Venom Factor, Naja naja kaouthia

233552
Cenu nelze zjistit
Minimum Quantity needs to be mulitiple of
S dokončenou objednávkou Další informace
Ušetřili jste ()
 
Vyžádat nacenění
Omezená dostupnostOmezená dostupnost
Na skladě 
Přerušeno
Dostupné omezené množství
Dostupnost bude potvrzena
    Remaining : Will advise
      Remaining : Will advise
      Bude poskytnuto
      Kontaktujte Zákaznický servis
      Contact Customer Service
      Zobrazit ceny a dostupnost

      Přehled

      Replacement Information

      Ceny a dostupnost

      Katalogové číslo DostupnostBalení ks/bal. Cena Množství
      233552-1MG
      Zjišťuji dostupnost...
      Omezená dostupnostOmezená dostupnost
      Na skladě 
      Přerušeno
      Dostupné omezené množství
      Dostupnost bude potvrzena
        Remaining : Will advise
          Remaining : Will advise
          Bude poskytnuto
          Kontaktujte Zákaznický servis
          Contact Customer Service

          Plastová ampulka 1 mg
          Zjišťuji cenu...
          Cenu nelze zjistit
          Minimum Quantity needs to be mulitiple of
          S dokončenou objednávkou Další informace
          Ušetřili jste ()
           
          Vyžádat nacenění
          Description
          OverviewNative cobra venom factor from Naja naja kaouthia. Glycoprotein composed of three non-identical disulfide-bonded subunits with M.W. of 68 kDa (α), 48 kDa (β), and 30 kDa (γ). Cobra venom factor (CVF) is a structural and functional analog of cobra, as well as mammalian C3. Thus, in the presence of Factor B, Factor D, and Mg2+, CVF can form a stable CVF,Bb complex that is a C3/C5 convertase enzyme; however, the CVF,Bb complex is not susceptible to regulation by Factors H and I. Four to six µg of purified CVF are equal to 1.0 unit of functional activity as measured by the method of Cochrane, et al.
          Catalogue Number233552
          Brand Family Calbiochem®
          SynonymsCobra Venom Anticomplementary Protein
          References
          ReferencesBogers, W.M., et al. 1993. Eur. J. Immunol. 23, 433.
          Fritzinger, D.C., et al. 1992. J. Immunol. 149, 3554.
          Muller, B. and Muller-Ruchholtz, W. 1987. Leuk. Res. 11, 461.
          Vogel, C.W. and Muller-Eberhard, H.J. 1984. J. Immunol. Methods 73, 203.
          Cochrane, C.G., et al. 1970. J. Immunol. 105, 55.
          Ballows, M. and Cochrane, C.G. 1969. J. Immunol. 103, 944.
          Product Information
          Activity≥250 units/ml
          DeclarationNot available for sale outside the United States.
          FormLiquid
          FormulationIn PBS, pH 7.2.
          Quality LevelMQ100
          Applications
          Biological Information
          Purity≥95% by SDS-PAGE
          Concentration Label Please refer to vial label for lot-specific concentration
          Physicochemical Information
          ContaminantsPhospholipase: none detected
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          R PhraseR: 20/21/22

          Harmful by inhalation, in contact with skin and if swallowed.
          S PhraseS: 36

          Wear suitable protective clothing.
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Dry Ice Only
          Toxicity Harmful
          Storage ≤ -70°C
          Avoid freeze/thaw Avoid freeze/thaw
          Do not freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          Cobra Venom Factor, Naja naja kaouthia MSDS

          Title

          Safety Data Sheet (SDS) 

          Cobra Venom Factor, Naja naja kaouthia Certificates of Analysis

          TitleLot Number
          233552

          References

          Přehled odkazů
          Bogers, W.M., et al. 1993. Eur. J. Immunol. 23, 433.
          Fritzinger, D.C., et al. 1992. J. Immunol. 149, 3554.
          Muller, B. and Muller-Ruchholtz, W. 1987. Leuk. Res. 11, 461.
          Vogel, C.W. and Muller-Eberhard, H.J. 1984. J. Immunol. Methods 73, 203.
          Cochrane, C.G., et al. 1970. J. Immunol. 105, 55.
          Ballows, M. and Cochrane, C.G. 1969. J. Immunol. 103, 944.
          Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision20-December-2010 JSW
          SynonymsCobra Venom Anticomplementary Protein
          DescriptionNative cobra venom factor from Naja naja kaouthia. Glycoprotein composed of three nonidentical disulfide-bound subunits with M.W. of 68,000 (α), 48,000 (β), and 30,000 (γ). Cobra Venom Factor (CVF) is a structural and functional analog of cobra, as well as mammalian C3. In the presence of Factor B, Factor D, and Mg2+, CVF can form a stable CVF, Bb complex which is a C3/C5 convertase enzyme; however, the CVF,Bb complex is not susceptible to regulation by Factors H and I. Four to six µg of purified CVF is equal to 1.0 unit of functional activity as measured by the method of Cochrane, et al.
          FormLiquid
          FormulationIn PBS, pH 7.2.
          Concentration Label Please refer to vial label for lot-specific concentration
          Purity≥95% by SDS-PAGE
          ContaminantsPhospholipase: none detected
          Activity≥250 units/ml
          Storage ≤ -70°C
          Avoid freeze/thaw
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
          Toxicity Harmful
          ReferencesBogers, W.M., et al. 1993. Eur. J. Immunol. 23, 433.
          Fritzinger, D.C., et al. 1992. J. Immunol. 149, 3554.
          Muller, B. and Muller-Ruchholtz, W. 1987. Leuk. Res. 11, 461.
          Vogel, C.W. and Muller-Eberhard, H.J. 1984. J. Immunol. Methods 73, 203.
          Cochrane, C.G., et al. 1970. J. Immunol. 105, 55.
          Ballows, M. and Cochrane, C.G. 1969. J. Immunol. 103, 944.